Cambridge Technology Enterprises Hits Upper Circuit Limit Amidst Declining Investor Participation
Cambridge Technology Enterprises Ltd experienced notable trading activity today, reaching its upper circuit limit with a high of 44.91. The stock recorded a total traded volume of approximately 0.13778 lakh shares and demonstrated resilience despite a decline in delivery volume and underperformance relative to its sector.
Cambridge Technology Enterprises Ltd, a microcap player in the Computers - Software & Consulting industry, has shown significant activity today as it hit its upper circuit limit. The stock reached a high price of 44.91, reflecting a notable performance despite a last traded price of 41.6, which represents a change of -1.18 and a percentage change of -2.76.The stock's price band is set at 5%, indicating a robust trading range. Throughout the trading session, Cambridge Technology Enterprises recorded a total traded volume of approximately 0.13778 lakh shares, resulting in a turnover of around 0.0596 crore. The intraday low was noted at 41.0, showcasing the stock's resilience in maintaining its upper circuit limit.
Despite underperforming the sector by 1.39% and trading below its moving averages across various time frames, the stock's liquidity remains adequate for trading activities. The delivery volume has seen a significant decline, falling by 75.6% against the 5-day average, which may reflect changing investor participation.
In summary, Cambridge Technology Enterprises Ltd's performance today highlights its ability to reach an upper circuit limit, with a high price of 44.91, amidst a challenging trading environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
